Kensuke Matsuda, Akira Honda, Shunya Arai, Hiroaki Maki, Kumi Nakazaki, Mineo Kurokawa (Hematol., Tokyo Univ., Tokyo, Japan)

Keiko Fukunaga, Kazuhiro Ikegame, Katsuji Kaida, Takayuki Inoue, Satoshi Yoshihara, Kyoko Yoshihara, Yuko Osugi, Hiroya Tamaki, Masaya Okada, Hiroyasu Ogawa, Yoshihiro Fujimori (Hematology, Hyogo College of Medicine, Nishinomiya, Japan)

Souichi Shiratori, Hideki Goto, Junichi Sugita, Masahiro Onozawa, Masao Nakagawa, Kaoru Kahata, Eiko Hayase, Tomoyuki Endo, Daigo Hashimoto, Takanori Teshima (Department of Hematology, Hokkaido University Hospital, Sapporo, Japan)

Chikako Ohwada¹, Emiko Sakaida¹, Aiko Igarashi², Noriko Doki², Takehiko Mori³, Jun Kato³, Heiwa Kanamori⁴, Masatsugu Tanaka⁴, Shin Fujisawa⁵, Eriko Ogusa⁵, Masako Toyosaki⁶, Yasuyuki Aoyama⁶, Yoshinobu Kanda⁷, Hideki Nakasone⁷, Maki Hagihara⁸, Hiroaki Shimizu⁹, Seiko Kato¹⁰, Reiko Watanabe¹¹, Katsuhiro Shono¹², Rika Sakai¹³, Takeshi Saito¹⁴, Kensuke Usuki¹⁵, Chiaki Nakaseko¹⁶, Shinichiro Okamoto^3,17 (1.Department of Hematology, Chiba University Hospital, 2.Hematology Division, Tokyo Metropolitan Cancer, 3.Division of Hematology, Keio University School of Medicine, 4.Department of Hematology, Kanagawa Cancer Center, 5.Department of Hematology, Yokohama City University Medical Center, 6.Division of Hematology/Oncology, Tokai University School of Medicine, 7.Division of Hematology, Saitama Medical Center, Jichi Medical University, 8.Department of Hematology and Clinical Immunology, Yokohama City University, 9.Department of Hematology, Gunma University School of Medicine, 10.Department of Hematology, The Institute of Medical Science, Tokyo University, 11.Department of Hematology, Saitama Medical Center, Saitama Medical University, 12.Division of Hematology, Chiba Aoba Municipal Hospital, 13.Kanagawa Cancer Center Department of Medical Oncology, 14.Division of Clinical Oncology/Hematology, Jikei University, 15.Division of Hematology, NTT Medical Center Tokyo, 16.Department of Hematology, International University of Health and Welfare, 17.Kanto Study Group for Cell Therapy (KSGCT))

Goichi Yoshimoto¹, Yasuo Mori¹, Akihiko Numata¹, Koji Kato¹, Takahiro Maeda², Katsuto Takenaka¹, Toshihiro Miyamoto¹, Koichi Akashi^1,2 (1.Hematology, Oncology and Cardiovascular medicine, Kyushu University Hospital, Fukuoka, 2.Center for Cellular and Molecular Medicine, Kyushu University Hospital, Fukuoka)

Hiroyuki Muranushi¹, Takero Shindo¹, Masakatsu Hishizawa¹, Masahito Tokunaga², Atsushi Wake³, Nobuaki Nakano², Tetsuya Eto⁴, Michihiro Hidaka⁵, Kaname Miyashita⁶, Toshihiro Miyamoto⁷, Takahiro Fukuda⁸, Tatsuo Ichinohe⁹, Yoshiko Atsuta¹⁰, Koji Kato⁷ (1.Department of Hematology and Oncology, Kyoto University, Kyoto, Japan, 2.Imamura General Hospital, Kagoshima, Japan, 3.Toranomon Hospital, Tokyo, Japan, 4.Hamanomachi Hospital, Fukuoka, Japan, 5.National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan, 6.National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan, 7.Kyushu University Hospital, Fukuoka, Japan, 8.National Cancer Center Hospital, Tokyo, Japan, 9.Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan, 10.Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan)